(Q74621213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

12 November 2019

main subject

1 reference

M Cazzola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M G Matera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Di Perna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Calderaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Califano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Vinciguerra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

354-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic approaches to chronic obstructive pulmonary disease: an emerging consensus

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over Design

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

Multiple dose regimens. Impact on compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990121-4

7 January 2021

10.1016/S0954-6111(98)90121-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616538%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference